![]() | The
Wikimedia Foundation's
Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see
WP:PAID. For advice about reviewing paid contributions, see
WP:COIRESPONSE.
|
![]() | This article is rated Start-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||
|
Article says: "The development of a novel compound designed to shorten the duration or stop an LSD experience that would allow LSD to be more widely used in a therapeutic environment, was subsequently announced."
The 'novel compund' is Ketanserin which is not novel. Should we include this in the article? 2A02:3030:403:5585:1DB8:CBCD:B142:EACB ( talk) 15:23, 24 September 2021 (UTC)
The current title is "MindMed" which is sorta ambiguous. Every other page for a business has its designation in the title.
(I don't know how to change titles.) Sonderidk ( talk) 15:51, 16 June 2024 (UTC)
![]() | The
Wikimedia Foundation's
Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see
WP:PAID. For advice about reviewing paid contributions, see
WP:COIRESPONSE.
|
![]() | This article is rated Start-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||
|
Article says: "The development of a novel compound designed to shorten the duration or stop an LSD experience that would allow LSD to be more widely used in a therapeutic environment, was subsequently announced."
The 'novel compund' is Ketanserin which is not novel. Should we include this in the article? 2A02:3030:403:5585:1DB8:CBCD:B142:EACB ( talk) 15:23, 24 September 2021 (UTC)
The current title is "MindMed" which is sorta ambiguous. Every other page for a business has its designation in the title.
(I don't know how to change titles.) Sonderidk ( talk) 15:51, 16 June 2024 (UTC)